@article{oai:nagasaki-u.repo.nii.ac.jp:00026961,
 author = {Shingu, Keita and Murase, Takehiko and Yamamoto, Takuma and Abe, Yuki and Shinba, Yoriko and Mitsuma, Masahide and Umehara, Takahiro and Yamashita, Hiromi and Ikematsu, Kazuya},
 journal = {Scientific Reports},
 month = {Nov},
 note = {In sudden unexpected death in infancy cases, postmortem genetic analysis with next-generation sequencing potentially can extract candidate genes associated with sudden death. However, it is difficult to accurately interpret the clinically significant genetic variants. The study aim was to conduct trio analysis of cases of sudden unexpected death in infancy and their parents to more accurately interpret the clinically significant disease-associated gene variants associated with cause of death. From the TruSight One panel targeting 4813 genes we extracted candidate genetic variants of 66 arrhythmia-, 63 inherited metabolic disease-, 81 mitochondrial disease-, and 6 salt-losing tubulopathy-related genes in 7 cases and determined if they were de novo or parental-derived variants. Thirty-four parental-derived variants and no de novo variants were found, but none appeared to be related to the cause of death. Using trio analysis and an in silico algorithm to analyze all 4813 genes, we identified OBSCN of compound heterozygous and HCCS of hemizygous variants as new candidate genetic variants related to cause of death. Genetic analysis of these deceased infants and their living parents can provide more accurate interpretation of the clinically significant genetic variants than previously possible and help confirm the cause of death., Scientific Reports, 11, art. no. 21532; 2021},
 title = {Accurate interpretation of genetic variants in sudden unexpected death in infancy by trio-targeted gene-sequencing panel analysis},
 volume = {11},
 year = {2021}
}